Bo Kang
- Biochemistry top 5%
- Sulfur Compounds in Biology 5
- Cancer Research top 10%
- MicroRNA in disease regulation 5
-
- Pluripotent Stem Cells Research 11
- CRISPR and Genetic Engineering 9
- Renal and related cancers 5
- Epigenetics and DNA Methylation 3
- Plant Science top 10%
-
- Autophagy in Disease and Therapy 4
-
- Hydrogen's biological and therapeutic effects 4
- Journals
- Journal of Biological Chemistry (1 paper)PLANT PHYSIOLOGY (1 paper)Scientific Reports (5 papers)
- Partner nations
- ChinaSouth KoreaUnited States
In The Last Decade
Bo Kang
34 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 99
- Biochemistry 146
- Cancer Research 209
- Molecular Biology 490
- Plant Science 257
- Cell Biology 107
Countries citing papers authored by Bo Kang
This map shows the geographic impact of Bo Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Kang more than expected).
Fields of papers citing papers by Bo Kang
This network shows the impact of papers produced by Bo Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Kang. The network helps show where Bo Kang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bo Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 6 | |
| 7 | 2021 | 3 | |
| 8 | 2020 | 27 | |
| 9 | 2020 | 1 | |
| 10 | 2019 | 18 | |
| 11 | 2017 | 21 | |
| 12 | 2016 | 29 | |
| 13 | 2016 | 28 | |
| 14 | 2015 | 2 | |
| 15 | 2015 | 62 | |
| 16 | 2015 | 38 | |
| 17 | 2014 | 14 | |
| 18 | Hydrogen sulfide inhibits endoplasmic reticulum stress-mediated apoptosis of cardiomyocytes by regulating the expression of microRNA-455 | 2014 | 2 |
| 19 | 2014 | 12 | |
| 20 | 2011 | 153 |
About Bo Kang
Bo Kang is a scholar working on Biochemistry, Molecular Medicine and Cancer Research, having authored 36 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (11 papers), CRISPR and Genetic Engineering (9 papers), Renal and related cancers (5 papers), MicroRNA in disease regulation (5 papers), Sulfur Compounds in Biology (5 papers), Autophagy in Disease and Therapy (4 papers), Hydrogen's biological and therapeutic effects (4 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Biochemistry (146 citations), Cancer Research (209 citations) and Molecular Biology (490 citations). Bo Kang has collaborated with scholars based in China, South Korea and United States. Frequent co-authors include Zhinong Wang, Xin Ni, Xiaoyan Zhu, Yufeng Zhang, Bin He, Jian Xiao, Jian Xiao, Yingjie Wang, Young Soo Kim and Youhuang Bai. Their work appears in journals such as Journal of Biological Chemistry, PLANT PHYSIOLOGY and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.